by Alison Bass | Jun 28, 2011 | conflicts of interest, pharmaceutical industry
Two quick notes: the Project on Government Oversight (POGO) has posted a helpful FAQ on corporate-funded medical ghostwriting. As POGO investigator Paul Thacker writes: “We hope this [FAQ] will answer any questions you might have on this very disturbing practice...
by Alison Bass | Jun 27, 2011 | biotech industry, conflicts of interest, drug marketing, health care costs, medical devices, pharmaceutical industry
A page-one story in The Boston Globe today spotlights the Massachusetts biotech industry’s effort to block a key piece of President Obama’s health care overhaul: the creation of an independent payment advisory board (IPAB) that would make recommendations...
by Alison Bass | Jun 8, 2011 | antidepressants, conflicts of interest, expert testimony, medical devices, National Institutes of Health
A few weeks ago, I blogged about the strange case of Dr. Helen Mayberg, a neurologist at Emory University who has testified in more death penalty cases in recent years than almost any other doctor in the country. I highlighted Mayberg’s lucrative and lethal (she...
by Alison Bass | May 17, 2011 | conflicts of interest, expert testimony, medical devices, National Institutes of Health, patient care
A year ago, the Department of Health and Human Services proposed new rules governing the disclosure and handling of financial conflicts of interest by medical researchers who receive federal funding. The more stringent rules were prompted by Congressional findings...
